Wattana Karnpaet Correlations
| NEW Stock | THB 107.00 10.00 8.55% |
The current 90-days correlation between Wattana Karnpaet Public and Thonburi Medical Centre is -0.35 (i.e., Very good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Wattana Karnpaet moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Wattana Karnpaet Public moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Wattana |
The ability to find closely correlated positions to Wattana Karnpaet could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Wattana Karnpaet when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Wattana Karnpaet - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Wattana Karnpaet Public to buy it.
Moving together with Wattana Stock
Moving against Wattana Stock
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Wattana Stock performing well and Wattana Karnpaet Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Wattana Karnpaet's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NTV | 0.79 | (0.11) | 0.00 | (2.32) | 0.00 | 1.71 | 6.99 | |||
| KDH | 0.67 | (0.10) | 0.00 | 1.57 | 0.00 | 1.84 | 7.39 | |||
| M-CHAI | 1.04 | (0.39) | 0.00 | (2.02) | 0.00 | 1.63 | 9.33 | |||
| AHC | 1.26 | (0.11) | 0.00 | (0.58) | 0.00 | 1.36 | 21.40 | |||
| RAM | 0.75 | (0.23) | 0.00 | (1.81) | 0.00 | 1.51 | 6.46 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Wattana Karnpaet without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Wattana Karnpaet Corporate Management
Elected by the shareholders, the Wattana Karnpaet's board of directors comprises two types of representatives: Wattana Karnpaet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Wattana. The board's role is to monitor Wattana Karnpaet's management team and ensure that shareholders' interests are well served. Wattana Karnpaet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Wattana Karnpaet's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Natthira Tangsubkul | Assisting CFO | Profile | |
| Pattharaporn Promtong | Sec | Profile | |
| Arunee Pothip | Head Division | Profile | |
| Suphawan Tangsubkul | Vice MD | Profile | |
| Sitichai Ungklomklieow | Head Director | Profile |